相关实验视频
Updated: Mar 11, 2026

06:51
Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
35.3K
衰老中的STAT3悖论:分子机制和有针对性的治疗策略
Tianshu Yang1, Shengqi Huo1, Wei Shi1
1Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, Hubei, China, 430030.
Ageing research reviews
|March 9, 2026
概括
信号转换器和转录3激活器 (STAT3) 在衰老中具有双重作用. 针对其翻译后修改 (PTMs) 为健康衰老疗法提供了潜力.
科学领域:
- 老龄化的分子机制.
- 细胞信号通道是细胞信号通道.
- 转录因子的生物化学
背景情况:
- 人口老龄化是一个全球性挑战,其分子基础不明.
- 信号传感器和转录3激活器 (STAT3) 涉及到衰老的特征,显示复杂的角色.
- 通过各种后翻译修饰 (PTM) 来调节STAT3的活性.
研究的目的:
- 在衰老中审查STAT3结构和PTM.
- 阐明STAT3酸化 (Y705,S727) 在衰老中的双重作用.
- 讨论针对STAT3的抗衰老策略和挑战.
主要方法:
- 在老化中对STAT3的文献综述.
- 对STAT3结构和PTM (酸化,乙化,甲基化) 的分析.
- 讨论STAT3的取决于上下文的角色和治疗向.
主要成果:
- 在Y705的STAT3酸化通常通过炎症和SASP促进衰老.
- 在S727的STAT3酸化和其他PTM可以提供抗衰老的好处.
- STAT3的矛盾作用取决于细胞类型,信号交叉通话和激活时间.
结论:
- 在衰老过程中,STAT3的复杂,上下文依赖的作用是由PTMs介导的.
- 针对STAT3 PTMs为抗衰老干预提供了有希望的途径.
- 对于STAT3疗法的精确向和临床转化,需要进一步的研究.
相关概念视频
Aging
938
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
938
Pharmacodynamics in Geriatric Patients: Effects of Age
306
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
306
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
291
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
291
PI3K/mTOR/AKT Signaling Pathway
6.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.1K
Mitochondria
21.1K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.1K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
60
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
60

